Directory · CA
Biotechnology in Canada
A register of firms and the professionals working at them in the Biotechnology sector based in Canada. Browse the public index, then filter or export on Kipplo.
Companies
245 on file
Network Immunology
Network Immunology Inc.("NI") is a leading edge, Vancouver based biotech company developing a revolutionary immunotherapeutic platform called AbstimX™. Treatment with AbstimX™ re-balances and resets overactive immune systems, long-term. AbstimX™ has been shown to be applicable to many inflammatory diseases. In pre-clinical studies, AbstimX™ therapy has safely and effectively treated and prevented the development of a broad range of inflammatory diseases - from chronic allergies to autoimmunity. Mission and Vision: Our mission, is to majorly decrease the amount of suffering caused by inflammatory diseases, on a global scale. Our vision, is a world in which everyone has access to AbstimX™. Our Business Model: At Network Immunology, we create substantial and lasting value through the development of novel immunotherapeutics for licensing and commercialization of those products and their associated intellectual property. We invite you to join us on this journey to the commercialization of AbstimX™.
11 to 50 staff
Noblegen Inc
Noblegen is an advanced digital biology company that employs microorganisms to reshape the world’s linear food systems with efficient and affordable circular solutions. We are champions of science on a mission to reinvent our future and disrupt conventional practices to rebalance planet and life, using microbes and fermentation technology. In our first phase of commercialization we have reinvented the world’s approach to food & agriculture. Our next phases of commercialization include biomaterials, health, energy, and space, among other industries. The company currently employs over 55 people at its Peterborough, Ontario locations.
11 to 50 staff
Optimize Organics Inc
Optimize Organics is a purpose-driven Canadian company pioneering smart, sustainable solutions for growers of every size—from balcony gardeners to commercial greenhouses and broad-acre farms. Headquartered in Chilliwack, BC, we curate and manufacture organic soils, dry & liquid fertilizers, biological pest controls, and precision amendments that unlock the full power of living soil. Our online marketplace stocks everything from microbe-rich living-soil blends and compost-tea kits to predatory mites, nematodes, and custom nutrient packs—each product vetted to meet the Canadian Organic Regime (COR) permitted substances list. We provide science-based consulting that demystifies organic production, including fertility program design, integrated pest management (IPM) plans, and biological transition strategies that reduce synthetic inputs without compromising yield. Whether you’re chasing terroir-rich berries, craft-cannabis compliance, or simply healthier houseplants, let us translate cutting-edge research into practical field recipes. Our mission is straightforward: make organic cultivation accessible, profitable, and climate-positive for every demographic. We champion regenerative practices that build soil carbon, safeguard pollinators, and close nutrient loops—because thriving plants start with thriving ecosystems. Why growers choose Optimize Organics • One-stop shop for rigorously tested organic inputs and living soils • Proven biological IPM tools that safely replace synthetic pesticides • Customized fertility and pest-control programs tailored to your crop, region, and budget • Fast, reliable shipping across Canada • Transparent sourcing and education to help growers know their inputs From seedling to harvest, Optimize Organics delivers the technology, stewardship, and expertise required to cultivate stronger plants, richer soils, and a more resilient food system—today and for generations to come.
1 to 10 staff
Questat
Questat is a start-up company leveraging the founding entrepreneurs’ decades of experience and subject matter expertise, in the development of point of care blood analysis systems. We firmly believe in near patient testing and we are committed to delivering high-quality products and services, that patients and providers can rely on for consistently accurate and actionable information. We deploy unique innovative technologies, that not only transform diagnostic products, but also expand into new platforms and solutions with superior health and economic outcomes.
11 to 50 staff
Scopesys
ScopeSys is a dynamic startup that partners with pharmaceutical companies to bring single molecule imaging to the next level. Our unique Convex Lens-induced Confinement (CLiC) platform helps access crucial information for drug and vaccines delivery without the need for tethering chemistry.
1 to 10 staff
Universal Ibogaine Inc. Tsxv Ibo
Ibogaine is a plant derived neuroactive compound that appears to reset the brains of drug dependent individuals to a pre-addicted state. Ibogaine has demonstrated particular effectiveness in treating opioid use disorder. When applied according to a strict safety protocol, ibogaine appears to eliminate the most painful symptoms of opioid withdrawal and provides a several month window free of drug cravings. Dr Alberto Sola, co-founder of Universal Ibogaine has administered more ibogaine treatments than any other doctor in the world. Universal Ibogaine is a life sciences company, with a mission to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a Canadian Clinical Trial, and ultimately to utilize that protocol around the globe through future licensing agreements. UI is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Clinic that, when paired with the ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction.
11 to 50 staff
Willow Biosciences Inc
Willow Biosciences is a synthetic biology company focused on the development of bio-based processes for the production of ingredients, including those for consumer care, food & beverage, and pharmaceuticals. Our scientists engineer organisms to produce plant, animal, and petrochemical-derived ingredients through precision fermentation. Our processes are more sustainable, secure, and cost-effective than traditional extraction or chemical synthesis routes and typically provide the final products in higher purity.
11 to 50 staff
Xitebio Technologies Inc
We are a dynamic biotechnology company engaged in microbial technology and agri-inputs for Canadian, American, European, and South American agricultural markets. The Innovation, Research & Development facility at XiteBio Technologies is creating innovative, cost-competitive, eco-friendly product lines to increase agricultural production at a reduced input cost in an eco-friendly manner.
11 to 50 staff
Alethia Biotherapeutics Inc
Alethia Biotherapeutics Inc. is a biotechnology company based out of Montreal, QC, Canada.
11 to 50 staff
Canadian Pacifico Seaweeds
CPS provides consultation and farmer support throughout all phases of farming development from site selection & design to deployment & maintenance. We believe in setting you up for success and ensuring that success from seed to sales; we buy wholesale directly from our farmer’s, and distribute the largest seaweed supply in BC. In addition to raw supply, we also offer a variety of locally made, premium kelp products
11 to 50 staff
Dbiomed
We are a Canadian Owned Business. We offer our customers the highest level of Innovative and Sustainable products.
1 to 10 staff
Epitopea
A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen.
11 to 50 staff
I See U Healthy
REDOX Signaling Supplement has been Scientifically shown to signal the activation of genes that- Improve immune system health - Help maintain a healthy inflammatory response - Help maintain cardiovascular health and support arterial elasticity - Improve gut health and digestive enzyme production - Modulate hormone balance to support vitality and wellness A Life Changing Product REDOX Cell Signaling Supplement addresses cellular breakdown, starting at the genetic level. This supplement is created using a groundbreaking, patented process that reorganizes molecules of natural salt and purified water into redox signaling molecules and has been scientifically tested and shown to signal the activation of genetic pathways.
10001+ staff
Integrated Explorations
Integrated Explorations provides laboratory and consulting services for the food and environmental industries. Established in Guelph, Ontario in 1977, we offer an extensive array of services to our clients, including microbiological and chemistry testing, consulting services, contract research and development, bioreactor design and analysis, and rental laboratory space.
1 to 10 staff
Kmt Hepatech, Inc. - Phoenixbio Group
KMT Hepatech, Inc. is a part of PhoenixBio group since December 1, 2017 KMT Hepatech provides efficient and cost-effective in vivo research services utilizing platform technology of small animal model, the PXB-Mouse®. The PXB-Mouse® is a chimeric mouse model with humanized liver with stable human hepatocytes engraftment of over 70 per cent. In addition to in vivo services, KMT Hepatech will expand operations and start production of PXB-Cells® - hepatocytes isolated from a PXB-Mouse® liver. Due to the expanding interest in the humanized liver mouse model across a wide range of drug development fields, the company now offers services in the following areas: Infectious diseases, such as Hepatitis C, Hepatitis B and Malaria Safety toxicity: early assessment of potential hepatotoxicity in in vivo settings prior to first-in-human studies Characterization of human-type drug and lipoprotein metabolism in in vivo settings prior to first-in-human studies KMT Hepatech, Inc. owns an international patent portfolio that includes coverage of the uPA chimeric mouse model of HCV infection and on the uPA chimeric mouse for all potential applications including HBV, malaria and studies of toxicity, drug and lipoprotein metabolism. The PXB-Mouse® and PXB-Cells® are your essential tools for therapeutics and vaccine development.
11 to 50 staff
Rotman Research Institute At Baycrest
Baycrest is a leader in cognitive neuroscience and memory research, with the goal of transforming the journey of aging. The stellar reputation of the Rotman Research Institute reflects its ability to raise and answer fundamental questions about memory, aging and the neuroscience of cognition. The affiliated Kunin-Lunenfeld Applied & Evaluative Research Unit, through Baycrest Innovation, leads the way in demonstrating how this research informs applied, translational research around the world. Scientists at the Rotman Research Institute (RRI) continue to make new discoveries in cognitive neuroscience and develop new tools and techniques to apply this knowledge across a range of disciplines. With EEG, MEG, MRI and eye-tracking facilities devoted solely to research, as well as systems enabling the use of multiple imaging facilities simultaneously, the RRI is unique in Canada and one of a few such facilities in the world.
51 to 200 staff
Soricimed Biopharma Inc
Soricimed is a privately-held, clinical stage company dedicated to developing effective and novel targeted treatments for cancer. Since the discovery of a unique protein found in the venomous saliva of the northern short-tailed shrew in 2005, the company is committed to developing effective, highly targeted delivery peptides and powerful therapeutics for several types of solid tumour cancers, making an impact on those living with often devastating conditions. General Information and Guidelines: Soricimed strives to create informative and engaging online communities that share information in meaningful ways. We welcome and encourage your participation and engagement in thoughtful and respectful discourse.
1 to 10 staff
Synbio Canada
SynBio Canada is a volunteer-run national not-for-profit. Our team and community is distributed across Canada. Vision To ensure Canada’s leadership in the field of synthetic biology through the development and retention of synthetic biology expertise across the country. Mission To create, strengthen, and advocate for a coordinated community of enthusiasts, trainees, and researchers passionate about synthetic biology. What we do to accomplish our mission 1. Community build: Create a visible and connected community of researchers and enthusiasts 2. Fund: Provide financial support for the Canadian synbio community 3. Connect: Provide opportunities for synthetic biology enthusiasts to connect and share resources 4. Promote: Promote Canadian synthetic biology research and applications 5. Advocate: Act as a resource for evidence-based policy making and advocate for the needs of the Canadian synbio community
1 to 10 staff
Synbioblox
At SynBioBlox Innovations, we find ways to use synthetic biology to convert Greenhouse Gas (GHG) emissions into valuable products. Everything we do starts with a good idea. We focus on solving big problems by lining up deep market understanding and strategy with adequate resources, disciplined leadership, and a clear and simple value proposition. We look at existing biological processes that can separate and capture emissions and then work to design bio-platforms and pathways to convert those GHGs into valuable products and improved processes with large addressable market opportunities. Once we have a plan in place, we use leading edge data and tools supplemented by Artificial Intelligence (AI), Machine Learning (ML) and Genome Scale metabolic Models (GEMs) to accelerate the development process and rapidly screen out technological dead-ends. The results of our digital and simulation efforts are verified in vivo,in wet labs and bio-foundries for proof of concept and scale up. Then we decide if this good idea is a great idea. If it is, we look for ways to manufacture, license or collaborate to make this valuable product a reality.
1 to 10 staff
Yyz Pharmatech Inc
YYZ Pharmatech Inc.(“YYZ”) is a deep tech company advancing transformative medicines for patients by revealing first-in-class and novel cell-surface co-receptor drug targets that others miss. YYZ’s platform characterizes cell-surface receptor complexes with unprecedented sensitivity to derive the most compelling drug targets for new therapies. YYZ is a member of JLABS and a spinout from Professor John G. Marshall’s laboratory at Toronto Metropolitan University. Our pioneering science is built on a foundation of +150 publications and extensive collaboration with leading international institutions.
1 to 10 staff
Abiogen Development Services
Abiogen provides business development services to bioscience firms in support of research, product development, commercialization, and matchmaking for partnering. Deep diligence on research project plans, business plans,product ideas, including technical & market intelligence.
1 to 10 staff
C3i
C3i, is a full-service CDMO in Cell & Gene therapy, offering in-house services from, process development to commercial GMP manufacturing, Qc analytical development of tests and testing, biomarker development, immune monitoring, and CRO. We manufacture for Canada, US, and Europe Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies. Offer our clients a "one-stop-shop" solution for the development, translation, and commercialization of their products: Our services - GMP Manufacturing Unit for Cell and Gene therapies - in-house testing Qc, Biomarker-Diagnostic and test development - Clinical Research offering KOLs, protocol development, and Key patient access - Investment & support for innovative companies
51 to 200 staff
Charterra
CharTerra provides advisory and consulting services to the agricultural and bioenergy community in western Canada. Previously known as AirTerra which was founded in 2009, CharTerra builds on the expertise of its seasoned professionals in the fields of biochar, bioenergy, soil amendments, horticulture, waste management and project management. CharTerra is pleased to work with First Nations and Metis organizations to support environmentally and economically sustainable projects in their communities.
1 to 10 staff
Cresswell Advisors Inc
The Principal is the recipient of the 2017 Julia Levy Award from the Chemical Institute of Canada, the 2016 Leadership Award from Life Sciences Ontario and the 2012 Gold Leaf Award for Industry Leadership from BIOTECanada. Cresswell is an advisory and consultancy providing assistance, direction and governance principally to development-stage public and private companies in the life sciences and early-stage and established companies in multiple fields. Formerly a Governor of the Toronto Stock Exchange, the Principal has been a member of the Awards Selection Committee of Canada's Network of Centers of Excellence, the Multidisciplinary Assessment Committee of the Canada Foundation for Innovation, and of the Ontario Biotechnology Advisory Board. He was the Founding Chairman of YM BioSciences Inc and CEO from 1998-2010, Founding Chairman of Formation Biologics, Executive Chairman of Stem Cell Therapeutics (now Trillium Therapeutics), a board member of Avivagen Inc, lead director of Diamedica Inc. and is currently a board member of Life Sciences Ontario. In 1992 he created the first Investment banking team in Canada providing research into and financing of life-sciences companies resulting in the creation of numerous companies including Drug Royalty Corporation and YM BioSciences Inc. Drug Royalty was the first public company in the world to invest in biopharmaceuticals through the royalty stream and YM became the first company from any major-market country to joint venture with the Cuban government for the commercialization of its biopharmaceuticals, the first company in the world to achieve Orphan Drug Designation from the FDA for a Cuban-origin drug, clearance from the FDA for the treatment of US patients with such drugs and the first to receive approval from the US Office of Foreign Assets Control to import Cuban-origin therapeutics into the United States.
1 to 10 staff
